Discontinuation report LESCOL XL
Report ID | 109153 |
Drug Identification Number | 02250527 |
Brand name | LESCOL XL |
Common or Proper name | LESCOL XL 80MG 2X14 |
Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | FLUVASTATIN |
Strength(s) | 80MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL |
Packaging size | 2X14 |
ATC code | C10AA |
ATC description | LIPID MODIFYING AGENTS, PLAIN |
Reason for discontinuation | Manufacturing issues |
Anticipated discontinuation date | 2020-04-03 |
Actual discontinuation date | 2020-04-03 |
Remaining supply date | 2020-04-03 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2020-03-20 | English | Compare |
v2 | 2020-03-20 | French | Compare |
v3 | 2020-04-17 | English | Compare |
v4 | 2020-04-17 | French | Compare |
Showing 1 to 4 of 4